Craig Tooman
Chief Executive Officer presso SILENCE THERAPEUTICS PLC
Patrimonio netto: 57 087 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Craig Tooman
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
25
| Public Company | Pharmaceuticals: Major | 25 |
| Public Company | Pharmaceuticals: Major | 22 | |
| Public Company | Miscellaneous Commercial Services | 19 | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany.
18
| Subsidiary | Biotechnology | 18 |
| Public Company | Biotechnology | 16 | |
| Extinct | Pharmaceuticals: Major | 9 | |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX.
6
| Extinct | Biotechnology | 6 |
| Holding Company | Biotechnology | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Craig Tooman tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Rochester Christian University | College/University | Undergraduate Degree Undergraduate Degree | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Compliance Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
| TIGENIX NV | Medical Specialties | Chairman Chairman | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Sarissa Capital Management LP
 Sarissa Capital Management LP Investment ManagersFinance Sarissa Capital Management LP (Sarissa) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded in 2012 by Alexander Denner and Mayuran Sriskandarajah. Sarissa provides investment advisory services to pooled investment vehicles operating as private investment funds. | Investment Managers | Chief Executive Officer Founder | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree | |
| GROUPE BRUXELLES LAMBERT SA | Financial Conglomerates | Director/Board Member Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Public Communications Contact | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| BNP PARIBAS FORTIS SA | Major Banks | Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Graduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| The University of Edinburgh | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| Seton Hall University | College/University | Undergraduate Degree Undergraduate Degree | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University College London | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| King's College London | College/University | Graduate Degree Undergraduate Degree | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Chief Executive Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| dievini Verwaltungs GmbH | Chief Executive Officer Chief Executive Officer | ||
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology BePharBel Manufacturing SA manufactures and distributes pharmaceutical products. Its products include drugs, tuberculosis and food supplements and cosmetics. The company was founded on March 26, 2012 and is headquartered in Courcelles, Belgium. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services OncoDNA SA develops and provides diagnostic and analytical tools for cancer treatment. The firm offers treatment options, integrated biological review, monitoring, pathology and DNA sequencing. The company was founded by Jean-Pol Detiffe on November 29, 2012 and is headquartered in Gosselies, Belgium. | Medical/Nursing Services | Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Tessa Therapeutics Ltd
 Tessa Therapeutics Ltd BiotechnologyHealth Technology Tessa Therapeutics Pte Ltd. engages in the development and commercialization of cancer immunotherapies. The firm has recruitment sites in Singapore, Malaysia, Taiwan, Thailand and the United States. The company was founded by Malcolm Brenner and Andrew Khoo and is headquartered in Singapore. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Chairman | |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Part of Johnson & Johnson, Vaxxilon AG is a Swiss company that develops and manufactures novel synthetic vaccines. The private company is based in Reinach, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Gsk Biologicals is a Belgian company that specializes in researching, developing, and manufacturing pharmaceutical medicines, vaccines, and consumer healthcare products. The private company is based in Wavre, Belgium. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services BESIX Group NV engages in the provision of construction and engineering solutions. Its business units include real estate, contracting, and concessions and assets. The real estate business realizes residential and office buildings in prime locations. The Contracting business comprises buildings, marine works, infrastructure, industry, environment; and sports and leisure. The concessions and assets business acquires, invests, operates, and maintains projects. The company was founded in 1909 and is headquartered in Woluwe-Saint-Lambert, Belgium. | Engineering & Construction | Chairman Director/Board Member | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 23 |
| Germania | 9 |
| Belgio | 8 |
| Regno Unito | 5 |
| Svizzera | 4 |
Settori
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 8 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Posizioni
| Director/Board Member | 477 |
| Corporate Officer/Principal | 233 |
| Chairman | 116 |
| Independent Dir/Board Member | 92 |
| Chief Executive Officer | 80 |
Contatti più connessi
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Iain Ross | 41 |
| Friedrich von Bohlen und Halbach | 36 |
| Baron Jean Stéphenne | 36 |
| Evan S. Melrose | 32 |
| Carolyn Cross | 30 |
| James Ede-Golightly | 29 |
| Michael Davidson | 27 |
| Alexander Denner | 25 |
| Hans Tanner | 24 |
| Richard L. Love | 23 |
| Jean Duvall | 22 |
| Gregory Weaver | 22 |
| David Lemus | 22 |
| Jean Charest | 20 |
- Borsa valori
- Insiders
- Craig Tooman
- Connessioni Società
